Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+2.20%
+8.02%
-1.48%
GERN
Geron
$1.23
Chart
1.59
2.54
3.6
3.32
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.20%
+8.02%
-1.48%
GERN
Geron
$1.23
Chart
1.59
2.54
3.6
3.32
GERN Latest Headlines
Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now.
Tue May 13, 2025
Geron slips as Scotiabank downgrades on sales challenges for blood cancer drug.
Thu May 8, 2025
Geron reports mixed Q1 results. reaffirms FY25 outlook.
Wed May 7, 2025
Holzer & Holzer LLC Reminds Investors of the May 12 2025 Lead Plaintiff Deadline in Shareholder Class Action Lawsuits Against Geron Corporation (GERN) and Fluence Energy Inc. (FLNC). Geron Corporation (GERN)) alleges that Defendants disseminated materially false and/or misleading statements and/or concealed material adverse facts concerning Rytelo'.s (imetelstat) potential between
Tue May 6, 2025
Geron Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi &. Korsinsky Before May 12 2025 to Discuss Your Rights - GERN. NEW YORK May 6 2025 /PRNewswire/ -- Levi & Korsinsky LLP notifies investors in Geron Corporation (Geron or the Company) (NASDAQ: GERN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Geron investors who were adversely...
Tue May 6, 2025
Levi &. Korsinsky Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12 2025 - GERN. NEW YORK May 2 2025 /PRNewswire/ -- Levi & Korsinsky LLP notifies investors in Geron Corporation (Geron or the Company) (NASDAQ: GERN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Geron investors who were adversely...
Fri May 2, 2025
GERN LAWSUIT ALERT: Levi &. Korsinsky Notifies Geron Corporation Investors of a Class Action Lawsuit and Upcoming Deadline. NEW YORK April 29 2025 /PRNewswire/ -- Levi & Korsinsky LLP notifies investors in Geron Corporation (Geron or the Company) (NASDAQ: GERN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Geron investors who were adversely...
Tue Apr 29, 2025
Geron Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 12 2025 to Discuss Your Rights – GERN. NEW YORK April 24 2025 (GLOBE NEWSWIRE) -- Levi &. Korsinsky LLP notifies investors in ) of a class action securities lawsuit. or by telephone at (212) 363-7500.
Thu Apr 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GERN Stock trends
GERN Stock performance
GERN Stock analysis
GERN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Don't Be a Sheep, Be a StocksRunner
StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score
Sign up for free and
continue analysing GERN
Already a Member? Click here to Login
Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.
Don't Be a Sheep, Be a StocksRunner
StocksRunner Aggregates The Most Important Headlines Into A Single Credibility Score
Sign up for free and
continue analysing GERN
Already a Member? Click here to Login
Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.
Login to display Geron (GERN) recommendation from the last 90 days from financial news and social media.
Hover over the category for more information
